AstraZeneca and Summit Therapeutics Partner on ADC Cancer Strategy
AstraZeneca has announced strategic equity investment and clinical collaboration with Summit Therapeutics to advance leading ADC combination strategy in cancer.
Ivonescimab AstraZeneca Collaboration | 01/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy